CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.4. KEY ONCOLOGY INFORMATION SYSTEMS AVAILABLE IN THE MARKET
3.5. MARKET SHARE ANAYSIS, 2016
3.6. REGULATION OF ONCOLOGY INFORMATION SYSTEM
3.7. MARKET DYNAMICS
3.7.1. Drivers
3.7.1.1. Availability of OIS with improved features
3.7.1.2. Increase in prevalence of cancer cases
3.7.1.3. Advantages of OIS over conventional record maintenance practices
3.7.2. Restraints
3.7.2.1. Dearth of healthcare IT professionals
3.7.2.2. High costs associated with OIS systems
3.7.3. Opportunities
3.7.3.1. Untapped potential of emerging markets
3.7.3.2. Use of artificial intelligence (AI) in oncology information systems
CHAPTER 4 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. SOFTWARE
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Patient information systems
4.2.4.1. Market size and forecast
4.2.5. Treatment planning systems
4.2.5.1. Market size and forecast
4.3. SERVICE
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Consulting/Optimization services
4.3.4.1. Market size and forecast
4.3.5. Implementation services
4.3.5.1. Market size and forecast
4.3.6. Post-sale & maintenance services
4.3.6.1. Market size and forecast
CHAPTER 5 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. MEDICAL ONCOLOGY
5.2.1. Market size and forecast
5.3. RADIATION ONCOLOGY
5.3.1. Market size and forecast
5.4. SURGICAL ONCOLOGY
5.4.1. Market size and forecast
CHAPTER 6 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. HOSPITALS & ONCOLOGY CLINICS
6.2.1. Market size and forecast
6.3. RESEARCH CENTERS
6.3.1. Market size and forecast
CHAPTER 7 ONCOLOGY INFORMATION SYSTEMS MARKET, BY GEOGRAPHY
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Rest of Europe market size and forecast
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. Rest of Asia-Pacific market size and forecast
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. South Africa market size and forecast
7.5.3.5. Rest of LAMEA market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1. ACCURAY INCORPORATED
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. BOGARDUS MEDICAL SYSTEMS, INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.3. CERNER CORPORATION
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. CURE MD CORPORATION
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Key strategic moves and developments
8.5. ELEKTA AB
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. FLATIRON HEALTH, INC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Key strategic moves and developments
8.7. KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. MCKESSON CORPORATION
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. RAYSEARCH LABORATORIES AB
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Product portfolio
8.9.4. Business performance
8.9.5. Key strategic moves and developments
8.10. VARIAN MEDICAL SYSTEMS, INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
